PYXS Pyxis Oncology
- 1.900
- -0.200-9.52%
- 1.890
- -0.010-0.52%
Pyxis Oncology News
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Pyxis Oncology | 10-Q: Q3 2024 Earnings Report
Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for Third Quarter 2024
Pyxis Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurion Capital Management LP(6.15%),Benjamin Alexander Smith(6.15%), etc.
Pyxis Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bayer World Investments B.V.(4.7%),Bayer Aktiengesellschaft(4.7%)
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | DEF 14A: Definitive information statements
Pyxis Oncology | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Pyxis Oncology | 10-Q: Q2 2024 Earnings Report
Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for Second Quarter 2024
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Metzger Michael A
Pyxis Oncology | 3: Initial statement of beneficial ownership of securities-Director Metzger Michael A
Pyxis Oncology | 8-K: Current report
Pyxis Oncology | 4: Statement of changes in beneficial ownership of securities-Director Palani Santhosh
Pyxis Oncology | 10-Q: Q1 2024 Earnings Report
Pyxis Oncology | 8-K: Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 May 14, 2024
Pyxis Oncology | ARS: Annual Report to Security Holders
Pyxis Oncology | DEFA14A: Others
Analysis
Price Target
No Data
No Data